Top

Supportive Care in Cancer

Published in:

01-04-2016 | Letter to the editor

Designing an integrative gynecologic oncology model of supportive care: call for a cross-cultural international collaboration

Authors: Eran Ben-Arye, Noah Samuels, Elad Schiff, Ofer Lavie

Published in: Supportive Care in Cancer | Issue 4/2016

Excerpt

Dear Editor-in-Chief …

http://link.springer.com/article/10.1007/s00520-015-3022-0

Ben-Arye E, Samuels N, Schiff E, Raz OG, Sharabi IS, Lavie O (2015) Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy. Support Care Cancer 23(12):3411–3419CrossRefPubMed

Rithirangsriroj K, Manchana T, Akkayagorn L (2015) Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients. Gynecol Oncol 136(1):82–86CrossRefPubMed

Ben-Arye E, Aharonson ML, Schiff E, Samuels N (2015) Alleviating gastro-intestinal symptoms and concerns by integrating patient-tailored complementary medicine in supportive cancer care. Clin Nutr 34(6):1215–1223CrossRefPubMed

Dwairy M (2002) Foundations of psychosocial dynamic personality theory of collective people. Clin Psychol Rev 22(3):345–362CrossRefPubMed

Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, Charalambous H, Dweikat T, Ghrayeb I, Bar-Sela G, Turker I, Hassan A, Hassan E, Saad B, Nimri O, Kebudi R, Silbermann M (2015) Potential risks associated with traditional herbal medicine use in cancer care: a study of MiddleEastern oncology health care professionals. Cancer. doi:10.1002/cncr.29796 PubMed

Title: Designing an integrative gynecologic oncology model of supportive care: call for a cross-cultural international collaboration
Authors: Eran Ben-Arye
Noah Samuels
Elad Schiff
Ofer Lavie
Publication date: 01-04-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 4/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3093-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2016

Polypharmacy cut-points in older people with cancer: how many medications are too many?

Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors

A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer

Medication use by early-stage breast cancer survivors: a 1-year longitudinal study

Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories

Understanding the impact of taste changes in oncology care

Keynote webinar | Spotlight on antibody–drug conjugates in cancer